{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:57:14Z","timestamp":1789268234349,"version":"build-2803163510"},"reference-count":88,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,4,8]]},"DOI":"10.3233\/jad-180995","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T13:09:16Z","timestamp":1551791356000},"page":"969-981","source":"Crossref","is-referenced-by-count":90,"title":["Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"68","author":[{"given":"Jason","family":"Brandt","sequence":"first","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Buchholz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbie","family":"Henry-Barron","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Translational Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Vizthum","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Translational Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Avramopoulos","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie C.","family":"Cervenka","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180995_ref1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s disease drug-development pipeline: Few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-180995_ref2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13668-014-0111-5","article-title":"Let food be thy medicine: Diet, nutrition, and biomarkers\u2019 risk of Alzheimer\u2019s disease","volume":"4","author":"Mosconi","year":"2015","journal-title":"Curr Nutr Rep"},{"key":"10.3233\/JAD-180995_ref3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/ern.11.56","article-title":"Diet and Alzheimer\u2019s disease risk factors or prevention: The current evidence","volume":"11","author":"Solfrizzi","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JAD-180995_ref4","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.nut.2013.01.024","article-title":"Nutritional approaches in the risk reduction and management of Alzheimer\u2019s disease","volume":"29","author":"Mi","year":"2013","journal-title":"Nutrition"},{"key":"10.3233\/JAD-180995_ref5","first-page":"48","article-title":"Diet and Alzheimer\u2019s disease: What the evidence shows","volume":"6","author":"Morris","year":"2004","journal-title":"MedGenMed"},{"key":"10.3233\/JAD-180995_ref6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ana.20898","article-title":"Diet and the risk for Alzheimer\u2019s disease","volume":"59","author":"Kawas","year":"2006","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-180995_ref7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11910-007-0057-8","article-title":"Diet and Alzheimer\u2019s disease","volume":"7","author":"Luchsinger","year":"2007","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.3233\/JAD-180995_ref8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1017\/S0007114515000926","article-title":"Diet, nutrients and metabolism: Cogs in the wheel driving Alzheimer\u2019s disease pathology?","volume":"113","author":"Creegan","year":"2015","journal-title":"Br J Nutr"},{"key":"10.3233\/JAD-180995_ref9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","article-title":"Associations between serum cholesterol levels and cerebral amyloidosis","volume":"71","author":"Reed","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-180995_ref10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(05)70248-9","article-title":"Cholesterol in Alzheimer\u2019s disease","volume":"4","author":"Shobab","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180995_ref11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurobiolaging.2004.09.003","article-title":"Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer\u2019s disease","volume":"26","author":"Poirier","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180995_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0009-9163.2004.00280.x","article-title":"Cholesterol at the crossroads: Alzheimer\u2019s disease and lipid metabolism","volume":"66","author":"Wellington","year":"2004","journal-title":"Clin Genet"},{"key":"10.3233\/JAD-180995_ref13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease","volume":"137","author":"Kivipelto","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.3233\/JAD-180995_ref14","first-page":"377","article-title":"Relation between cholesterol levels, statins and Alzheimer\u2019s disease in the human population","volume":"6","author":"Austen","year":"2002","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-180995_ref15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/WNL.54.1.240","article-title":"Serum cholesterol, APOE genotype, and the risk of Alzheimer\u2019s disease: A population-based study of African Americans","volume":"54","author":"Evans","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-180995_ref16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer\u2019s disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JAD-180995_ref17","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/ana.20854","article-title":"Mediterranean diet and risk for Alzheimer\u2019s disease","volume":"59","author":"Scarmeas","year":"2006","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-180995_ref18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-180995_ref19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00001756-200203250-00019","article-title":"Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice","volume":"13","author":"Shie","year":"2002","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-180995_ref20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jalz.2014.11.009","article-title":"MIND diet associated with reduced incidence of Alzheimer\u2019s disease","volume":"11","author":"Morris","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180995_ref21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCHEARTFAILURE.113.000495","article-title":"Mediterranean and DASH diet scores and mortality in women with heart failure: The Women\u2019s Health Initiative","volume":"6","author":"Levitan","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.3233\/JAD-180995_ref22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000213592","article-title":"Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer\u2019s disease","volume":"40","author":"Meier-Ruge","year":"1994","journal-title":"Gerontology"},{"key":"10.3233\/JAD-180995_ref23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer\u2019s disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180995_ref24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: A systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180995_ref25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(08)70021-8","article-title":"Cognition and diabetes: A lifespan perspective","volume":"7","author":"Biessels","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180995_ref26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"key":"10.3233\/JAD-180995_ref27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2004.02.048","article-title":"Modulation of memory by insulin and glucose: Neuropsychological observations in Alzheimer\u2019s disease","volume":"490","author":"Watson","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-180995_ref28","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","article-title":"Reduced hippocampal metabolism in MCI and AD: Automated FDG-PET image analysis","volume":"64","author":"Mosconi","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-180995_ref29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180995_ref30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-180995_ref31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180995_ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nut.2010.07.021","article-title":"Brain fuel metabolism, aging, and Alzheimer\u2019s disease","volume":"27","author":"Cunnane","year":"2011","journal-title":"Nutrition"},{"key":"10.3233\/JAD-180995_ref33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-180995_ref34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","article-title":"Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer\u2019s disease, and other dementias","volume":"49","author":"Mosconi","year":"2008","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-180995_ref35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mad.2016.05.005","article-title":"Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer\u2019s disease brain","volume":"161","author":"Abolhassani","year":"2017","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-180995_ref36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3233\/JAD-141074","article-title":"Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer\u2019s disease dementia","volume":"43","author":"Castellano","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180995_ref37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.exger.2017.07.004","article-title":"A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer\u2019s disease","volume":"107","author":"Croteau","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-180995_ref38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1528-1167.2007.01256.x","article-title":"A prospective study of the modified Atkins diet for intractable epilepsy in adults","volume":"49","author":"Kossoff","year":"2008","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-180995_ref39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1542\/peds.2006-2447","article-title":"The ketogenic diet: One decade later","volume":"119","author":"Freeman","year":"2007","journal-title":"Pediatrics"},{"key":"10.3233\/JAD-180995_ref40","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1542\/peds.102.6.1358","article-title":"The efficacy of the ketogenic diet-1998: A prospective evaluation of intervention in 150 children","volume":"102","author":"Freeman","year":"1998","journal-title":"Pediatrics"},{"key":"10.3233\/JAD-180995_ref41","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1528-1167.2012.03406.x","article-title":"E-mail management of the modified Atkins Diet for adults with epilepsy is feasible and effective","volume":"53","author":"Cervenka","year":"2012","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-180995_ref42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/1476830514Y.0000000162","article-title":"The impact of the modified Atkins diet on lipid profiles in adults with epilepsy","volume":"19","author":"Cervenka","year":"2016","journal-title":"Nutr Neurosci"},{"key":"10.3233\/JAD-180995_ref43","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3945\/an.116.012138","article-title":"Mediterranean diet, cognitive function, and dementia: A systematic review of the evidence","volume":"7","author":"Petersson","year":"2016","journal-title":"Adv Nutr"},{"key":"10.3233\/JAD-180995_ref44","doi-asserted-by":"crossref","first-page":"425 e419","DOI":"10.1016\/j.neurobiolaging.2010.10.006","article-title":"Dietary ketosis enhances memory in mild cognitive impairment","volume":"33","author":"Krikorian","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180995_ref45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trci.2017.11.002","article-title":"Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer\u2019s disease","volume":"4","author":"Taylor","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-180995_ref46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1381612820666141020164222","article-title":"The APOE genotype: Modification of therapeutic responses in Alzheimer\u2019s disease","volume":"21","author":"Hanson","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-180995_ref47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial","volume":"69","author":"Craft","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-180995_ref48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180995_ref49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.50.3.669","article-title":"Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer\u2019s disease","volume":"50","author":"Farlow","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-180995_ref50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(97)80089-X","article-title":"APOE genotyping and response to drug treatment in Alzheimer\u2019s disease","volume":"349","author":"Richard","year":"1997","journal-title":"Lancet"},{"key":"10.3233\/JAD-180995_ref51","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3233\/JAD-122308","article-title":"Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer\u2019s disease","volume":"35","author":"Claxton","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180995_ref52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1743-7075-6-31","article-title":"Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer\u2019s disease: A randomized, double-blind, placebo-controlled, multicenter trial","volume":"6","author":"Henderson","year":"2009","journal-title":"Nutr Metab (Lond)"},{"key":"10.3233\/JAD-180995_ref53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0197-4580(03)00087-3","article-title":"Effects of beta-hydroxybutyrate on cognition in memory-impaired adults","volume":"25","author":"Reger","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180995_ref54","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1017\/S1041610214001203","article-title":"Researchers\u2019 perspectives on the role of study partners in dementia research","volume":"26","author":"Black","year":"2014","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-180995_ref55","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.0000000000003690","article-title":"Phase I\/II multicenter ketogenic diet study for adult superrefractory status epilepticus","volume":"88","author":"Cervenka","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-180995_ref56","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-180995_ref57","volume-title":"Mini-Mental State Examination","author":"Folstein","year":"2012"},{"key":"10.3233\/JAD-180995_ref58","first-page":"637","article-title":"Clinical Dementia Rating (CDR)","volume":"24","author":"Berg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.3233\/JAD-180995_ref59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12877-015-0103-3","article-title":"Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults","volume":"15","author":"Trzepacz","year":"2015","journal-title":"BMC Geriatr"},{"key":"10.3233\/JAD-180995_ref60","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1212\/WNL.0b013e318230208a","article-title":"Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample","volume":"77","author":"Rossetti","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-180995_ref61","volume-title":"Hopkins Verbal Learning Test \u2013 Revised","author":"Brandt","year":"2001"},{"key":"10.3233\/JAD-180995_ref62","volume-title":"Brief Visuospatial Memory Test-Revised","author":"Benedict","year":"1997"},{"key":"10.3233\/JAD-180995_ref63","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2466\/pr0.1985.56.3.779","article-title":"Comparisons of psychiatric outpatients with controls on Bipolar Profile of Mood States","volume":"56","author":"Myhill","year":"1985","journal-title":"Psychol Rep"},{"key":"10.3233\/JAD-180995_ref64","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jpainsymman.2004.10.004","article-title":"Mood swings: Variability in the use of the Profile of Mood States","volume":"28","author":"Edwards","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.3233\/JAD-180995_ref65","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00005650-200012000-00005","article-title":"Minimum data set for home care: A valid instrument to assess frail older people living in the community","volume":"38","author":"Landi","year":"2000","journal-title":"Med Care"},{"issue":"Suppl 8","key":"10.3233\/JAD-180995_ref66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1528-1167.2008.01831.x","article-title":"The modified Atkins diet","volume":"49","author":"Kossoff","year":"2008","journal-title":"Epilepsia"},{"key":"10.3233\/JAD-180995_ref67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diabet.2006.11.006","article-title":"Correlation between urine ketones (acetoacetate) and capillary blood ketones (3-beta-hydroxybutyrate) in hyperglycaemic patients","volume":"33","author":"Taboulet","year":"2007","journal-title":"Diabetes Metab"},{"key":"10.3233\/JAD-180995_ref68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.yebeh.2016.02.038","article-title":"Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges","volume":"58","author":"Cervenka","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.3233\/JAD-180995_ref69","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yebeh.2011.03.008","article-title":"Dietary treatments for epilepsy: Management guidelines for the general practitioner","volume":"21","author":"Lee","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.3233\/JAD-180995_ref70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0169-2607(89)90122-3","article-title":"Computerized collection and analysis of dietary intake information","volume":"30","author":"Feskanich","year":"1989","journal-title":"Comput Methods Programs Biomed"},{"key":"10.3233\/JAD-180995_ref71","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3945\/jn.113.183079","article-title":"The Healthy Eating Index-2010 is a valid and reliable measure of diet quality according to the 2010 Dietary Guidelines for Americans","volume":"144","author":"Guenther","year":"2014","journal-title":"J Nutr"},{"key":"10.3233\/JAD-180995_ref72","doi-asserted-by":"crossref","first-page":"53","DOI":"10.22237\/jmasm\/1414814520","article-title":"Some general guidelines for choosing missing data handling methods in educational research","volume":"13","author":"Cheema","year":"2014","journal-title":"J Mod Appl Stat Methods"},{"key":"10.3233\/JAD-180995_ref73","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1109\/32.965340","article-title":"Analysing data sets with missing data: An empirical evaluation of imputation methods and likelihood-based methods","volume":"27","author":"Myrtveit","year":"2001","journal-title":"IEEE Trans Softw Eng"},{"key":"10.3233\/JAD-180995_ref74","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3892\/ijo.2014.2382","article-title":"ERGO: A pilot study of ketogenic diet in recurrent glioblastoma","volume":"44","author":"Rieger","year":"2014","journal-title":"Int J Oncol"},{"key":"10.3233\/JAD-180995_ref75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2288-10-17","article-title":"Recruiting older people to a randomised controlled dietary intervention trial - how hard can it be?","volume":"10","author":"Forster","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.3233\/JAD-180995_ref76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3988\/jcn.2015.11.1.26","article-title":"Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: A meta-analysis","volume":"11","author":"Ye","year":"2015","journal-title":"J Clin Neurol"},{"key":"10.3233\/JAD-180995_ref77","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1007\/s00213-016-4414-7","article-title":"Effect of a ketogenic meal on cognitive function in elderly adults: Potential for cognitive enhancement","volume":"233","author":"Ota","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-180995_ref78","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/awp132","article-title":"Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer\u2019s disease","volume":"132","author":"Fouquet","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-180995_ref79","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","article-title":"MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET","volume":"63","author":"Mosconi","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-180995_ref80","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-160395","article-title":"Topographical APOE varepsilon4 genotype influence on cerebral metabolism in the continuum of Alzheimer\u2019s disease: Amyloid burden adjusted analysis","volume":"54","author":"Seo","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180995_ref81","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.neurobiolaging.2014.03.006","article-title":"18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons","volume":"35","author":"Knopman","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180995_ref82","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jalz.2017.12.003","article-title":"Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting","volume":"14","author":"Snitz","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180995_ref83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-clinpsy-032816-045136","article-title":"Subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"13","author":"Rabin","year":"2017","journal-title":"Annu Rev Clin Psychol"},{"key":"10.3233\/JAD-180995_ref84","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jalz.2016.09.012","article-title":"Implementation of subjective cognitive decline criteria in research studies","volume":"13","author":"Molinuevo","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"Suppl 1","key":"10.3233\/JAD-180995_ref85","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3233\/JAD-150719","article-title":"Subjective cognitive decline","volume":"48","author":"Tales","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180995_ref86","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180995_ref87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180995_ref88","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:18Z","timestamp":1777370958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-180995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":88,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-180995","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]}}}